# Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor

> **NCT05455918** · PHASE2 · RECRUITING · sponsor: **Yonsei University** · enrollment: 42 (estimated)

## Conditions studied

- Pediatric Germ Cell Tumor

## Interventions

- **DRUG:** TIP treatment (paclitaxel/ifosfamide/cisplatin)

## Key facts

- **NCT ID:** NCT05455918
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-07-26
- **Primary completion:** 2025-06
- **Final completion:** 2028-06
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2022-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05455918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05455918, "Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05455918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*